Literature DB >> 17319662

Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.

Victor K Tam1, Denise Kwong, Yitzhak Tor.   

Abstract

The HIV-1 Dimerization Initiation Site (DIS) is an intriguing, yet underutilized, viral RNA target for potential antiretroviral therapy. To study the recognition features of this target and to provide a quantitative, rapid, and real-time tool for the discovery of new binders, a fluorescence-based assay has been constructed. It relies on strategic incorporation of 2-aminopurine, an isosteric fluorescent adenosine analogue, into short hairpin RNA constructs. These oligomers self-associate to form a kissing loop that thermally rearranges into a more stable extended duplex, thereby mimicking the association and structural features of the native RNA sequence. We demonstrate the ability of two fluorescent DIS constructs, DIS272(2AP) and DIS273(2AP), to report the binding of known DIS binders via changes in their emission intensity. Binding of aminoglycosides such as paromomycin to DIS272(2AP) results in significant fluorescence enhancement, while ligand binding to DIS273(2AP) results in fluorescence quenching. These observations are rationalized by comparison to the sequence-analogous bacterial A-site, where the relative emission of the fluorescent probe is dependent on the placement of the flexible purine residues inside or outside the helical domain. Analysis of binding isotherms generated using DIS272(2AP) yields submicromolar EC50 values for paromomycin (0.5 +/- 0.2 microM) and neomycin B (0.6 +/- 0.2 microM). Other neomycin-family aminoglycosides are less potent binders with neamine, the core pharmacophore, displaying the lowest affinity of 21 +/- 1 microM. Screening of additional aminoglycosides and their derivatives led to the discovery of new, previously unreported, aminoglycoside binders of the HIV DIS RNA, among them butirosin A (5.5 +/- 0.6 microM) and apramycin (7.6 +/- 1.0 microM). A conformationally constrained neomycin B analogue displays a rather high affinity to the DIS (1.9 +/- 0.2 microM). Among a series of nucleobase aminoglycoside conjugates, only the uracil derivatives display a measurable affinity using this assay with EC50 values in the 2 microM range. In addition, similarity between the solution behavior of HIV-1 DIS and the bacterial decoding A-site has been observed, particularly with respect to the intra- and extra-helical residence of the conformationally flexible A residues within the bulge. Taken together, the observations reported here shed light on the solution behavior of this important RNA target and are likely to facilitate the design of new DIS selective ligands as potential antiretroviral agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17319662      PMCID: PMC2525870          DOI: 10.1021/ja0675797

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  76 in total

1.  Multiple secondary structure rearrangements during HIV-1 RNA dimerization.

Authors:  Hendrik Huthoff; Ben Berkhout
Journal:  Biochemistry       Date:  2002-08-20       Impact factor: 3.162

2.  Monitoring molecular recognition of the ribosomal decoding site.

Authors:  Sarah Shandrick; Qiang Zhao; Qing Han; Benjamin K Ayida; Masayuki Takahashi; Geoffrey C Winters; Klaus B Simonsen; Dionisios Vourloumis; Thomas Hermann
Journal:  Angew Chem Int Ed Engl       Date:  2004-06-14       Impact factor: 15.336

Review 3.  Tat and Rev: positive regulators of HIV gene expression.

Authors:  C A Rosen; G N Pavlakis
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

4.  Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.

Authors:  Malvika Kaul; Christopher M Barbieri; Daniel S Pilch
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

5.  An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA.

Authors:  H Miyaguchi; H Narita; K Sakamoto; S Yokoyama
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

6.  Polymorphism of bulged-out residues in HIV-1 RNA DIS kissing complex and structure comparison with solution studies.

Authors:  Eric Ennifar; Philippe Dumas
Journal:  J Mol Biol       Date:  2005-12-21       Impact factor: 5.469

7.  Structural origins of gentamicin antibiotic action.

Authors:  S Yoshizawa; D Fourmy; J D Puglisi
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.

Authors:  M L Zapp; S Stern; M R Green
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

9.  Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine.

Authors:  Nathan W Luedtke; Peter Carmichael; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2003-10-15       Impact factor: 15.419

10.  Solution studies of the dimerization initiation site of HIV-1 genomic RNA.

Authors:  F Dardel; R Marquet; C Ehresmann; B Ehresmann; S Blanquet
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

View more
  13 in total

1.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

Review 2.  Fluorescent analogs of biomolecular building blocks: design, properties, and applications.

Authors:  Renatus W Sinkeldam; Nicholas J Greco; Yitzhak Tor
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Emissive RNA alphabet.

Authors:  Dongwon Shin; Renatus W Sinkeldam; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2011-09-02       Impact factor: 15.419

4.  Conformation-sensitive nucleoside analogues as topology-specific fluorescence turn-on probes for DNA and RNA G-quadruplexes.

Authors:  Arun A Tanpure; Seergazhi G Srivatsan
Journal:  Nucleic Acids Res       Date:  2015-07-21       Impact factor: 16.971

5.  Ligand- and pH-induced conformational changes of RNA domain helix 69 revealed by 2-aminopurine fluorescence.

Authors:  Yogo Sakakibara; Sanjaya C Abeysirigunawardena; Anne-Cécile E Duc; Danielle N Dremann; Christine S Chow
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-24       Impact factor: 15.336

6.  Dissecting structural transitions in the HIV-1 dimerization initiation site RNA using 2-aminopurine fluorescence.

Authors:  Hui-Wen Lee; Katharine T Briggs; John P Marino
Journal:  Methods       Date:  2009-05-19       Impact factor: 3.608

7.  Characterization and use of an unprecedentedly bright and structurally non-perturbing fluorescent DNA base analogue.

Authors:  Peter Sandin; Karl Börjesson; Hong Li; Jerker Mårtensson; Tom Brown; L Marcus Wilhelmsson; Bo Albinsson
Journal:  Nucleic Acids Res       Date:  2007-11-14       Impact factor: 16.971

8.  Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion.

Authors:  Serena Bernacchi; Séverine Freisz; Clarisse Maechling; Bernard Spiess; Roland Marquet; Philippe Dumas; Eric Ennifar
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

9.  Ligand-induced folding of the thiM TPP riboswitch investigated by a structure-based fluorescence spectroscopic approach.

Authors:  Kathrin Lang; Renate Rieder; Ronald Micura
Journal:  Nucleic Acids Res       Date:  2007-08-09       Impact factor: 16.971

10.  Probing Human Telomeric DNA and RNA Topology and Ligand Binding in a Cellular Model by Using Responsive Fluorescent Nucleoside Probes.

Authors:  Sudeshna Manna; Cornelia H Panse; Vyankat A Sontakke; Sarangamath Sangamesh; Seergazhi G Srivatsan
Journal:  Chembiochem       Date:  2017-07-10       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.